Helical Tomotherapy for High-Risk Oral Cavity Cancer
Author Information
Author(s): Hsieh Chen-Hsi, Kuo Ying-Shiung, Liao Li-Jen, Hu Kawang-Yu, Lin Shih-Chiang, Wu Le-Jung, Lin Yu-Chin, Chen Yu-Jen, Wang Li-Ying, Hsieh Yen-Ping, Lin Shoei Long, Chen Chun-Yi, Chen Chien-An, Shueng Pei-Wei
Primary Institution: Far Eastern Memorial Hospital, Taipei, Taiwan
Hypothesis
The study aims to assess the treatment results and toxicity profiles of helical tomotherapy for postoperative high-risk oral cavity cancer.
Conclusion
Helical tomotherapy achieved encouraging clinical outcomes for postoperative high-risk oral cavity cancer patients with high compliance.
Supporting Evidence
- The 2-year overall survival rate was 94%.
- The disease-free survival rate was 84%.
- The locoregional control rate was 92%.
- The distant metastasis-free rate was 94%.
- 42% of patients experienced grade 3 mucositis.
Takeaway
Doctors used a special type of radiation treatment called helical tomotherapy on patients with mouth cancer after surgery, and it worked well with few side effects.
Methodology
Nineteen postoperative high-risk oral cavity cancer patients were treated with helical tomotherapy, with or without chemotherapy, and followed for clinical outcomes and toxicity.
Limitations
The small case number and retrospective design limit the ability to draw statistical conclusions, and the follow-up time is short.
Participant Demographics
Seventeen men and 2 women, median age 50 years, with various risk factors including positive surgical margins and extracapsular spread.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website